Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0000950170-25-043903

Director sold 22,682 shares at $8.00 ($181,456)

  • Director acquired 22,682 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hasnain Faheem · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-21 Exercise or conversion : show line 1 in the form +22,682 $6.32 $143,350 46,665 D
2025-03-21 Sale : show line 2 in the form −22,682 $8.00 $181,456 23,983 D
Open-market sales · 22,682 sh · avg $8.00 · $181,456
Loading xslF345X05/ownership.xml…